Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Recombinant human alpha-N-acetylglucosaminidase

EU orphan designation number: EU/3/13/1144   
Active ingredient: Recombinant human alpha-N-acetylglucosaminidase
Indication: Treatment of mucopolysaccharidosis type IIIB (Sanfilippo B syndrome)
Sponsor: Synageva BioPharma Ltd
c/o Kevin Beare & Company, Forest House, 3-5 Horndean Road, Bracknell, Berkshire RG12 0XQ, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/06/2013 Centralised Orphan - Designation EMA/OD/035/13 (2013)3965 of 19/06/2013